The HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013.
The HSE has advised that the FreeStyle Libre glucose monitoring device is not currently available on the Irish market. In the event of this equipment being made available, and an application for reimbursement being received by the HSE, a health technology assessment may be required to assess its clinical benefits and cost effectiveness.